Alzheimer's drug donanemab helps most when taken at earliest disease stage, study finds - Nature.com
- Alzheimer's drug donanemab helps most when taken at earliest disease stage, study finds Nature.com
- US drugmaker: Alzheimer's development can be slowed down | DW News DW News
- Second Alzheimer’s drug to slow disease’s progression may be approved in the US this year CNN
- Newspaper review: 'Breakthrough Alzheimer's drug' and Greek wildfires BBC
- Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety risk NEWS CENTER Maine
- View Full Coverage on Google News